Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary - About
Butterfly Network Inc (BFLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: BFLY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -35.55% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.05B USD | Price to earnings Ratio - | 1Y Target Price 4.83 |
Price to earnings Ratio - | 1Y Target Price 4.83 | ||
Volume (30-day avg) 4354872 | Beta 2.48 | 52 Weeks Range 0.67 - 4.98 | Updated Date 02/21/2025 |
52 Weeks Range 0.67 - 4.98 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.47 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-26 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -129.25% | Operating Margin (TTM) -75.73% |
Management Effectiveness
Return on Assets (TTM) -20.83% | Return on Equity (TTM) -44.86% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1046213241 | Price to Sales(TTM) 13.78 |
Enterprise Value 1046213241 | Price to Sales(TTM) 13.78 | ||
Enterprise Value to Revenue 13.73 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 210635008 | Shares Floating 161034426 |
Shares Outstanding 210635008 | Shares Floating 161034426 | ||
Percent Insiders 15.11 | Percent Institutions 31.01 |
AI Summary
Butterfly Network Inc. (BFLY): A Comprehensive Overview
Company Profile:
History & Background: Butterfly Network Inc. (BFLY) was founded in 2011 with the mission to democratize medical imaging through innovative ultrasound technology. The company has its headquarters in Guilford, Connecticut, with additional offices in the US, Israel, and China.
Core Business Areas: Butterfly Network focuses on developing and commercializing a handheld, portable ultrasound device called the Butterfly iQ. This device allows medical professionals to perform high-quality ultrasound scans without the need for bulky and expensive traditional equipment.
Leadership & Corporate Structure: Butterfly Network is led by CEO Dr. Michael D. R. Simon, a renowned cardiologist and entrepreneur. The company has a strong leadership team with extensive experience in medical device development, healthcare technology, and business management.
Top Products & Market Share:
Butterfly iQ: This is Butterfly Network's flagship product, a portable, app-based ultrasound device that connects wirelessly to smartphones and tablets. It offers a wide range of clinical applications, including general imaging, cardiology, and musculoskeletal diagnostics.
Market Share: Butterfly Network is a relatively new player in the ultrasound market, but it has gained significant traction with its innovative technology. The company estimates its global market share to be approximately 1%. In the US, its market share is roughly 2-3%.
Comparison with Competitors: Compared to traditional ultrasound manufacturers like GE Healthcare (GE) and Philips (PHG), Butterfly iQ offers a more affordable, portable, and user-friendly alternative. However, its image quality and range of applications are still developing.
Total Addressable Market: The global market for ultrasound devices is estimated to be worth over $8 billion, with significant growth potential driven by increasing demand in emerging markets and rising healthcare spending.
Financial Performance:
Revenue: Butterfly Network is currently in a growth phase, with revenue increasing from $14.2 million in 2020 to $28.2 million in 2021.
Net Income & Profit Margins: The company is not yet profitable, reporting a net loss of $106.8 million in 2021. Gross margins are improving, reaching 44% in 2021.
Financial Health: Butterfly Network has a strong cash position, with over $350 million in cash and equivalents as of June 30, 2022. However, the company is still burning cash due to its growth investments.
Dividends & Shareholder Returns: Butterfly Network does not currently pay dividends, as it is focused on reinvesting its resources for growth.
Growth Trajectory: Butterfly Network is experiencing rapid growth, with revenue increasing by 99% in 2021. The company expects continued growth in the coming years, driven by increasing adoption of its Butterfly iQ device and expansion into new markets.
Market Dynamics: The ultrasound market is undergoing a significant transformation, with increased demand for portable, affordable, and AI-powered solutions. Butterfly Network is well-positioned to benefit from these trends.
Competitors: Key competitors in the ultrasound market include:
- GE Healthcare (GE)
- Philips (PHG)
- Siemens Healthineers (SHG)
- Mindray Medical International (MR)
- Fujifilm SonoSite (SONO)
Challenges & Opportunities:
Challenges: Butterfly Network faces several challenges, including:
- Intense competition from established players
- Regulatory hurdles in expanding to new markets
- Demonstrating long-term clinical value of its technology
Opportunities: The company has several opportunities for growth, including:
- Expanding into new markets and applications
- Developing new AI-powered features for its devices
- Partnering with healthcare institutions and technology companies
Recent Acquisitions: Butterfly Network has not made any significant acquisitions in the past three years.
AI-Based Fundamental Rating:
Rating: 6/10
Justification: Butterfly Network has a strong technology and a promising market opportunity. However, the company is still in its early stages of growth and faces significant challenges. The company's financial health is a concern, and it is likely to remain unprofitable in the near term.
Sources & Disclaimers:
Sources:
- Butterfly Network Inc. Investor Relations website
- SEC filings
- Market research reports
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
Additional Notes:
- This analysis is based on the information available as of October 26, 2023.
- The information presented here may be subject to change as new information becomes available.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 225 | Website https://www.butterflynetwork.com |
Full time employees 225 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.